News 13 set 2021 Incyte inaugurates its new production plant in Yverdon After establishing its European headquarters in Morges in 2020, American biopharmaceutical group Incyte strengthens its presence in the canton of...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO International Convention 2024 03 jun 2024–06 jun 2024 San Diego Estados Unidos
News 10 ago 2021 Women’s health biopharmaceutical company ObsEva receives USD 500 million ObsEva, a Geneva-based biopharmaceutical company dedicated to improving women’s reproductive health, will receive up to USD 500 million for the l...
S-GE Event Tomorrow's Health: Meet the Experts on Patient Data, Empowerment & Blockchain 17 jun 2021 17 jun 2021 Suíça
News 30 abr 2021 ADC Therapeutics receives FDA approval for its lymphoma cancer treatment ZYNLONTA Oncology biotechnology company ADC Therapeutics has received the first FDA approval for ZYNLONTA, its lead drug candidate for the treatment of ad...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO International Convention 2024 03 jun 2024–06 jun 2024 San Diego Estados Unidos
Press Release 30 jan 2024 Exports stagnant: Swiss companies adjust their expectations and strategies Swiss SMEs are still expecting minimal export growth in the coming months. This is the finding of the latest survey of Swiss SMEs conducted by Sw...
Press Release 11 jan 2021 Swiss start-ups at CES 2021 Switzerland will be participating in the Consumer Electronics Show (CES) for the third time in a row. From January 11-14, 2021, Switzerland Globa...
Actualités 20 dez 2017 Nouvelle procédure d’évaluation de la conformité aux Emirats arabes unis La nouvelle procédure vise à limiter l’utilisation de certaines substances dangereuses dans les équipements électriques et électroniques (RoHS: R...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO International Convention 2024 03 jun 2024–06 jun 2024 San Diego Estados Unidos